CIBC Bank USA’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-4,979
| Closed | -$221K | – | 270 |
|
2017
Q4 | $221K | Buy |
+4,979
| New | +$221K | 0.03% | 240 |
|
2017
Q3 | – | Sell |
-4,989
| Closed | -$268K | – | 278 |
|
2017
Q2 | $268K | Sell |
4,989
-4,121
| -45% | -$221K | 0.04% | 216 |
|
2017
Q1 | $480K | Sell |
9,110
-344
| -4% | -$18.1K | 0.07% | 156 |
|
2016
Q4 | $456K | Sell |
9,454
-564
| -6% | -$27.2K | 0.07% | 156 |
|
2016
Q3 | $540K | Sell |
10,018
-942
| -9% | -$50.8K | 0.08% | 144 |
|
2016
Q2 | $594K | Sell |
10,960
-512
| -4% | -$27.7K | 0.09% | 133 |
|
2016
Q1 | $582K | Buy |
11,472
+918
| +9% | +$46.6K | 0.1% | 123 |
|
2015
Q4 | $532K | Buy |
10,554
+335
| +3% | +$16.9K | 0.09% | 139 |
|
2015
Q3 | $491K | Buy |
10,219
+625
| +7% | +$30K | 0.09% | 143 |
|
2015
Q2 | $499K | Sell |
9,594
-130
| -1% | -$6.76K | 0.08% | 154 |
|
2015
Q1 | $561K | Sell |
9,724
-538
| -5% | -$31K | 0.1% | 141 |
|
2014
Q4 | $549K | Buy |
10,262
+3,522
| +52% | +$188K | 0.1% | 159 |
|
2014
Q3 | $387K | Sell |
6,740
-3,704
| -35% | -$213K | 0.08% | 201 |
|
2014
Q2 | $698K | Sell |
10,444
-1,540
| -13% | -$103K | 0.13% | 130 |
|
2014
Q1 | $800K | Buy |
11,984
+3,688
| +44% | +$246K | 0.17% | 111 |
|
2013
Q4 | $554K | Sell |
8,296
-427
| -5% | -$28.5K | 0.12% | 172 |
|
2013
Q3 | $547K | Sell |
8,723
-29,613
| -77% | -$1.86M | 0.13% | 167 |
|
2013
Q2 | $2.39M | Buy |
+38,336
| New | +$2.39M | 0.14% | 116 |
|